Preveceutical Medical Inc PRVCF

$0.01 +0.00 (5.79%)

Valuation

Market cap
7,521,000
Revenue TTM
$0
Net income TTM
$-1,130,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
-0.62

Trading

Volume
250
Avg volume
33,386
Day's range
$0.01 – $0.01
Shares out
621,587,000
Stochastic %K
48%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-bas...

Show more

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development of preventive and therapeutic products derived from organic and nature-identical compounds; synthesized Nature Identical; Sol-Gel Nose-to-Brain delivery platform for Parkinson's disease; develops cannabinoid-based nose-to-brain delivery system for the relief of a various ailments, including pain, inflammation, seizures, and neurological disorders; peptide library synthesis, pharmacological evaluation, alongside pharmacokinetic assessment, and determinations in animal models of pain and inflammation; and non-addictive analgesic peptides for pain management. It also involved in licensing, branding, and marketing nutraceutical and wellness products; Sol-Gel platform; and peptide program. PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 416 7777
Website
https://www.preveceutical.com
Address
5428 Marine Drive, West Vancouver, Canada

Latest news

No headlines yet.